ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
UK to expand NHS Subscription Pilot! Consultation Period launches
Reimbursing for innovative antibiotics / Encouraging updates from the AMR conference
Draft EMA antibacterial guidance: Analysis
The 37,000-year view: Infections in Eurasia
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR
Developing antibiotics for children: There are no easy answers
Push! Pull! Push! Pull! / Highlights from Davos 2018
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
What does an antibiotic cost to develop? What is it worth? How to afford it?
Non-traditional antibiotics: A pipeline review and an analysis of key development challenges
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
Lancet: 10-20-30 targets to address AMR by 2030
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet